Percutaneous recanalization for combined-type Budd-Chiari syndrome: strategy and long-term outcome

Verfasser / Beitragende:
[Yu-Fei Fu, Yu Li, Yan-Feng Cui, Ning Wei, De-Chun Li, Hao Xu]
Ort, Verlag, Jahr:
2015
Enthalten in:
Abdominal Imaging, 40/8(2015-10-01), 3240-3247
Format:
Artikel (online)
ID: 605494878
LEADER caa a22 4500
001 605494878
003 CHVBK
005 20210128100528.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s00261-015-0496-7  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00261-015-0496-7 
245 0 0 |a Percutaneous recanalization for combined-type Budd-Chiari syndrome: strategy and long-term outcome  |h [Elektronische Daten]  |c [Yu-Fei Fu, Yu Li, Yan-Feng Cui, Ning Wei, De-Chun Li, Hao Xu] 
520 3 |a Purpose: To investigate the feasibility, strategy, and long-term outcome of percutaneous recanalization for combined-type Budd-Chiari syndrome (BCS). Methods: From December 2007 to August 2014, consecutive symptomatic combined-type BCS patients were treated by percutaneous recanalization in our centers. Inferior vena cava (IVC) recanalization was the first-stage treatment for all patients. Recanalization of one hepatic vein (HV) was the second-stage treatment for the selected patients. If the patient had the compensatory and patent accessory HV (AHV), we observed this patient for 7days after IVC recanalization. If the symptoms of portal hypertension improved, HV recanalization was not needed. Otherwise, HV recanalization was performed. If the patient had no patent AHV, HV recanalization was performed 3days after IVC recanalization. Data on technical success, clinical success, and follow-up were analyzed, respectively. Results: Sixty-two symptomatic combined-type BCS patients were enrolled. Technical success of percutaneous recanalization was achieved in 60 patients. Among them, 52 patients had the patent AHV and underwent single IVC recanalization, and 8 patients had no patent AHV and underwent combined IVC and HV recanalization. Clinical success was achieved in all of the 60 patients. Three patients died during the follow-up. The cumulative 1-, 2-, and 4-year survival rates were 98.3%, 96.5%, and 92.7%, respectively. Conclusion: Percutaneous recanalization is suitable for most combined-type BCS patients. Treatment strategy can be made according to the situation of AHV. If the patient has the patent AHV, single IVC recanalization is enough. Otherwise, combined IVC and HV recanalization should be performed. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Budd-Chiari syndrome  |2 nationallicence 
690 7 |a Recanalization  |2 nationallicence 
690 7 |a Inferior vena cava  |2 nationallicence 
690 7 |a Hepatic vein  |2 nationallicence 
700 1 |a Fu  |D Yu-Fei  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
700 1 |a Li  |D Yu  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
700 1 |a Cui  |D Yan-Feng  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
700 1 |a Wei  |D Ning  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
700 1 |a Li  |D De-Chun  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
700 1 |a Xu  |D Hao  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
773 0 |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/8(2015-10-01), 3240-3247  |x 0942-8925  |q 40:8<3240  |1 2015  |2 40  |o 261 
856 4 0 |u https://doi.org/10.1007/s00261-015-0496-7  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00261-015-0496-7  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fu  |D Yu-Fei  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D Yu  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cui  |D Yan-Feng  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wei  |D Ning  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D De-Chun  |u Department of Radiology, Xuzhou Central Hospital, 199 South Jie-fang Road, 221009, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Xu  |D Hao  |u Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, 99 West Huai-hai Road, 221006, Xuzhou, China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/8(2015-10-01), 3240-3247  |x 0942-8925  |q 40:8<3240  |1 2015  |2 40  |o 261